Byline: Will Doss
-
Thompson Named President of American Society of Hematology
Alexis Thompson, MD, MPH, has been named president of the American Society of Hematology, the world’s largest hematology professional organization.
-
Medical Student Tackles Health Disparities in Hispanic Communities
Nicolás Francone, a first-year medical student, combines his interests in medicine and policy to reduce inequality in care delivery and improve access to healthcare for Hispanic patients.
-
Feinberg Appoints Inaugural Chief Research Informatics Officer
Feinberg reaffirmed its commitment to informatics and precision medicine by appointing Firas Wehbe, MD, PhD, as its first chief research informatics officer.
-
Blocking Gene Expression Improves Outcomes in Blood Disease in Models
Scientists reduced blood clotting in mice with a blood disease called myeloproliferative neoplasm by inhibiting expression of a gene.
-
Northwestern Explores Mummy’s Secrets With Particle Accelerator
A team from Northwestern Medicine used the most powerful X-ray source in the Western Hemisphere to examine an 1,800-year old mummy, seeking answers to questions about bone competence of ancient humans.
-
Regulatory Network Helps Cells Survive in Low Oxygen Environments
Northwestern Medicine scientists identified a complex regulatory system that keeps cells functioning when their oxygen supply is cut off.
-
Les Turner ALS Symposium Brings Together Investigators, Clinicians and Patients
The 7th Annual Les Turner Symposium showcased the integration of ALS investigation and clinical care at Northwestern Medicine and the Les Turner ALS Foundation.
-
New Strategic Research Plan for Feinberg
New cross-cutting themes and a disease focus area were added to Feinberg’s research strategy, strengthening the vision for years to come.
-
Exploring the Genetics of Glaucoma and Retinal Development
Northwestern Medicine scientists have discovered a genetic basis for glaucoma symptoms and the impact of other genes in early retinal development.
-
New Drugs Show Promise in Critically Ill Patients
Two Northwestern Medicine clinical trials investigated drugs to treat patients suffering from vasodilatory shock and respiratory failure, showing promising results.
